SCHEMBL22474026

SCHEMBL22474026

Cc1nncn1C1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KMT2A Q03164 1/20 0.37
PI4KA P42356 3/20 0.35
PI4K2B Q8TCG2 3/20 0.35
PI4K2A Q9BTU6 3/20 0.35
PI4KB Q9UBF8 3/20 0.35
ADORA2A P29274 3/20 0.35
ADORA3 P0DMS8 2/20 0.35
ADORA1 P30542 2/20 0.35
CCNT1 O60563 1/20 0.34
CDK9 P50750 1/20 0.34
HCAR1 Q9BXC0 4/20 0.33
RORC P51449 2/20 0.33
AURKA O14965 1/20 0.33
JAK2 O60674 1/20 0.33
PRKCA P17252 1/20 0.33
JAK1 P23458 1/20 0.33
KDR P35968 1/20 0.33
JAK3 P52333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22474028 0.98 PI4KA (0.37) MEN1ALDH1A1KMT2API4KAPI4K2B
SCHEMBL18912008 0.91
SCHEMBL22474029 0.82 HCAR1 (0.38) KMT2AHCAR1RORCJAK2JAK1
SCHEMBL16906236 0.82 ALOX15 (0.40) RORCJAK1SMN1; SMN2GAAALOX15
SCHEMBL32680234 0.75 ADORA2A (0.35) MEN1ALDH1A1KMT2API4KAPI4K2B
SCHEMBL23638593 0.75 ALDH1A1 (0.33) MEN1ALDH1A1KMT2API4KAPI4K2B
SCHEMBL21783961 0.75 CCNT1 (0.39) MEN1ALDH1A1KMT2API4KAPI4K2B
SCHEMBL6970733 0.73 PI4KA (0.37) MEN1ALDH1A1KMT2API4KAPI4K2B
SCHEMBL8179609 0.73 PI4KA (0.37) MEN1ALDH1A1KMT2API4KAPI4K2B
Hexazole SCHEMBL2111420 0.73 ALDH1A1 (0.35) MEN1ALDH1A1KMT2API4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3572401-B1 ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF FUJIAN COSUNTER PHARMACEUTICAL CO LTD (CN) 2021-09-29 EP disclosed
US-10787435-B2 ASK1 inhibitor and preparation method and use thereof Fuijan Cosunter Pharmaceutical Co. Ltd. (CN) 2020-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10787435-B2 ASK1 inhibitor and preparation method and use thereof MARK1, MAP3K1, MAP3K20 MEN1 648/4885ALDH1A1 3134/4885KMT2A 2254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.